Follicular lymphoma is considered an indolent disease, with long-term tumour control achieved by first-line ...
Georgie Swallow was just 28-years-old when she received the devastating news that she had stage 4 Hodgkin lymphoma ...
Medpage Today on MSN2d
Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin LymphomaNon-transplant salvage therapy for low-risk relapsed/refractory pediatric classical Hodgkin lymphoma (cHL) had high rates of ...
A young British woman who was hit with a devastating stage four cancer diagnosis in her late twenties explains how she ...
Dr John Leonard shares key updates on DLBCL at ASH 2024, including long-term POLARIX trial data, ctDNA insights, and real-world results for polatuzumab, liso-cel, and bispecifics after CAR-T failure.
Tevimbra is under clinical development by BeiGene and currently in Phase I for Ureter Cancer. According to GlobalData, Phase I drugs for Ureter Cancer does not have sufficient historical data to build ...
Tevimbra is under clinical development by BeiGene and currently in Phase II for Follicular Lymphoma. According to GlobalData, Phase II drugs for Follicular Lymphoma have a 43% phase transition success ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback